In contrast, the most prevalent group among cognitively normal 65–74 year olds in our hip fracture study was the preclinical AD category in which abnormal Aβ biomarker levels were accompanied by abnormal levels of either or both p-tau and t-tau. The gene discussed is MAPT; the disease is Alzheimer disease.